NCT03208348

Pilot Study of Virtual Reality for Providing Exposure Therapy to Children

Completed NA Last updated 24 April 2018

What this trial tests

NA trial testing Pilot Virtual Reality in Generalized Anxiety Disorder in 20 participants. Completed in 31 January 2018.

Timeline

1 September 2017

Primary endpoint
31 January 2018

31 January 2018

Quick facts

Lead sponsor	Minnesota HealthSolutions
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	20
Start date	1 September 2017
Primary completion	31 January 2018
Estimated completion	31 January 2018
Sites	1 location across United States

Drugs / interventions tested

• Pilot Virtual Reality

Conditions studied

• Generalized Anxiety Disorder — all drugs for Generalized Anxiety Disorder →

Sponsor

Minnesota HealthSolutions

Who can join

Adults 7 to 12, any sex, with Generalized Anxiety Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Drs. from the Mayo Clinic Rochester will plan and execute a feasibility study of the phase I prototype version of the Virtual Reality exposure therapy system. Dr. X, who has significant experience in evaluating patient experiences and opinions of technologies intended to change behavior, will oversee a qualitative study to examine the prototype system. Twenty children with generalized anxiety disorder with perfectionism who have received less than 3 treatment sessions and a parent will be recruited to pilot the Virtual Reality system.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.